Gastroenterology Research and Practice / 2020 / Article / Tab 2 / Research Article
Establishment and Verification of Synchronous Metastatic Nomogram for Gastrointestinal Stromal Tumors (GISTs): A Population-Based Analysis Table 2 Adjusted odds ratio (OR) with 95% confidence interval (CI) and
value for selected tumor and demographic characteristics as indicators of metastatic diseases among GIST patients.
Characteristics OR 95% CI valueGender 0.124 Female Reference 1.000 Male 1.146 0.963-1.363 0.124 Insurance 0.094 Yes Reference 1.000 No 1.475 0.944-2.305 0.088 NOS 0.878 0.706-1.092 0.244 Tumor location 0.001 Large intestine Reference 1.000 Peritoneum 2.185 1.156-4.131 0.016 Stomach 1.823 1.163-2.855 0.009 Small intestine 2.564 1.607-4.092 <0.001 Esophagus 1.445 0.293-7.120 0.651 Pathologic grade <0.001 I Reference 1.000 II 1.071 0.646-1.774 0.791 III 2.518 1.495-4.241 0.001 IV 2.798 1.721-4.551 <0.001 NOS 1.859 1.247-2.771 0.002 Tumor size (cm) <0.001 ≤2 Reference 1.000 2-5 2.366 1.353-4.138 0.003 5-10 3.516 2.040-6.060 <0.001 >10 5.370 3.110-9.272 <0.001 NOS 7.124 4.005-12.671 <0.001 Lymph nodes <0.001 Negative Reference 1.000 Positive 6.153 4.531-8.355 <0.001 NOS 3.991 3.035-5.249 <0.001 Extension <0.001 Mild Reference 1.000 Grievous 2.886 2.368-3.518 <0.001 NOS 3.991 3.035-5.249 <0.001 Mitotic count <0.001 ≤5/50 HPF Reference 1.000 >5/50 HPF 1.554 1.207-2.000 0.001 NOS 1.788 1.348-2.372 <0.001
NOS: not otherwise specified.